HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.

HLB Therapeutics Co.,Ltd.

115450

Kedudukan dalam Saham #18257
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Harga Saham
$2.02
Modal Pasaran
$190.66M
Perubahan (1 hari)
7.96%
Perubahan (1 tahun)
-1.16%
Negara
KR
Perdagangan HLB Therapeutics Co.,Ltd. (115450)

Kategori

Healthcare
Sejarah pecahan saham untuk HLB Therapeutics Co.,Ltd. (115450)
Saham HLB Therapeutics Co.,Ltd. (simbol: 115450) telah mengalami sejumlah 6 pecahan saham.
Pecahan saham terkini berlaku pada Mar 12, 2026.
Satu saham 115450 yang dibeli sebelum Dec 18, 2013 kini bersamaan dengan 1.49754041325 saham 115450.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2026-03-12 21:20 x1.05 x1.49754041325
2025-01-14 21:20 x1.05 x1.426228965
2023-12-27 207:200 x1.035 x1.3583133
2023-03-15 2:1 x2 x1.31238
2022-12-28 207:400 x0.5175 x0.65619
2013-12-18 317:250 x1.268 x1.268
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
US
1 x3
AU
1 x100
BE
0 -
NL